Antidiabetic Rosiglitazone Reduces Soluble Intercellular Adhesion Molecule-1 Level in Type 2 Diabetic Patients with Coronary Artery Disease
Background. We investigated the level of soluble adhesion molecules in diabetic patients and the effect of the peroxisome proliferator-activated receptor-γ (PPAR-γ) agonist rosiglitazone on plasma levels of adhesion molecules and an inflammation marker in type 2 diabetic patients with coronary arter...
Main Authors: | Guang Wang, Zhe Zhang, Jie Yu, Fuchun Zhang, Liyun He, Jinru Wei, Jieming Mao, Xian Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2008-01-01
|
Series: | PPAR Research |
Online Access: | http://dx.doi.org/10.1155/2008/548178 |
Similar Items
-
Effect of Mitral Stenosis Severity on Blood Soluble Vascular Cell Adhesion Molecule-1 and Soluble Intercellular Adhesion Molecule-1 Levels
by: Pramono Sigit, et al.
Published: (2015-03-01) -
Detection of soluble interleukin-2 receptor and soluble intercellular adhesion molecule-1 in the effusion of otitis media with effusion
by: T. Ganbo, et al.
Published: (1995-01-01) -
Association between Soluble Intercellular Adhesion Molecule-1 and Soluble Vascular Cell Adhesion Molecule-1 Levels and Left Atrial Thrombosis Gradation in Mitral Stenosis
by: Elen Elen, et al.
Published: (2016-02-01) -
Association between Soluble Intercellular Adhesion Molecule-1 and Soluble Vascular Cell Adhesion Molecule-1 Levels and Left Atrial Thrombosis Gradation in Mitral Stenosis
by: Elen Sahara,, et al.
Published: (2015-05-01) -
Association between the polymorphisms in intercellular adhesion molecule-1 and the risk of coronary atherosclerosis: a case-controlled study.
by: Mao Yang, et al.
Published: (2014-01-01)